当前位置:首页 - 行情中心 - 东亚药业(605177) - 财务分析 - 现金流量表

东亚药业

(605177)

  

流通市值:21.73亿  总市值:22.14亿
流通股本:1.13亿   总股本:1.15亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金280,416,803.57155,085,077.49665,942,354.07511,493,960.32
  收到的税费返还19,647,676.043,747,493.7838,400,005.126,659,620.28
  收到其他与经营活动有关的现金6,760,507.852,815,785.0175,530,336.7150,980,786.07
  经营活动现金流入小计306,824,987.46161,648,356.28779,872,695.88589,134,366.67
  购买商品、接受劳务支付的现金396,825,140.87211,678,832.8574,184,609.86458,510,617.45
  支付给职工以及为职工支付的现金109,225,340.8462,645,085.09227,197,786.62166,690,210.32
  支付的各项税费14,889,747.58,696,567.0735,266,519.6832,450,211.81
  支付其他与经营活动有关的现金23,223,162.2913,155,798.1899,773,545.1253,655,154.75
  经营活动现金流出小计544,163,391.5296,176,283.14936,422,461.28711,306,194.33
  经营活动产生的现金流量净额-237,338,404.04-134,527,926.86-156,549,765.4-122,171,827.66
二、投资活动产生的现金流量:
  收回投资收到的现金227,700,00060,000,000975,178,500595,000,000
  取得投资收益收到的现金742,567.6737,534.2423,528,481.7721,043,120.81
  处置固定资产、无形资产和其他长期资产收回的现金净额435,659.43169,376.381,572,321.5648,237
  收到的其他与投资活动有关的现金--167,000178,500
  投资活动现金流入小计228,878,227.160,206,910.621,000,446,303.27616,869,857.81
  购建固定资产、无形资产和其他长期资产支付的现金45,806,812.832,590,184.27211,605,252.92152,257,251.49
  投资支付的现金372,450,000212,450,000879,000,166.67739,400,000
  支付其他与投资活动有关的现金---3,250,632.15
  投资活动现金流出小计418,256,812.8245,040,184.271,090,605,419.59894,907,883.64
  投资活动产生的现金流量净额-189,378,585.7-184,833,273.65-90,159,116.32-278,038,025.83
三、筹资活动产生的现金流量:
  吸收投资收到的现金--20,710,875.41100,000
  其中:子公司吸收少数股东投资收到的现金--160,000100,000
  取得借款收到的现金284,280,000169,780,000204,400,000200,000,000
  收到其他与筹资活动有关的现金--98,311,238.8971,000,000
  筹资活动现金流入小计284,280,000169,780,000323,422,114.3271,100,000
  偿还债务支付的现金115,000,000100,000,000170,000,000170,500,000
  分配股利、利润或偿付利息支付的现金2,212,951.88930,550.6941,595,484.3140,740,575.24
  支付其他与筹资活动有关的现金1,433,071.88183,322.0880,287,321.878,072,084.01
  筹资活动现金流出小计118,646,023.76101,113,872.77291,882,806.11289,312,659.25
  筹资活动产生的现金流量净额165,633,976.2468,666,127.2331,539,308.19-18,212,659.25
四、汇率变动对现金及现金等价物的影响995,806.38659,238.732,538,141.991,875,841.11
五、现金及现金等价物净增加额-260,087,207.12-250,035,834.55-212,631,431.54-416,546,671.63
  加:期初现金及现金等价物余额488,325,966.27488,325,966.27700,957,397.81700,957,397.81
  期末现金及现金等价物余额228,238,759.15238,290,131.72488,325,966.27284,410,726.18
补充资料:
  净利润-30,264,551.62--100,699,459.5-
  资产减值准备31,980,426.01-144,052,482.6-
  固定资产和投资性房地产折旧69,588,281.9-129,947,919.68-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧69,588,281.9-129,947,919.68-
  无形资产摊销1,266,211.96-2,288,620.31-
  长期待摊费用摊销2,147,591.38-3,476,474.25-
  处置固定资产、无形资产和其他长期资产的损失4,303.49-3,130,864-
  固定资产报废损失1,697,729.25-12,425,358.73-
  财务费用4,100,112.13--498,479.19-
  投资损失-1,467,591.82--3,943,815.78-
  递延所得税-10,157,712.12--20,651,480.49-
  其中:递延所得税资产减少-10,306,278.1--20,356,524.3-
    递延所得税负债增加148,565.98--294,956.19-
  存货的减少-70,673,691.01--240,688,577.49-
  经营性应收项目的减少-76,246,777.6--270,558,770.79-
  经营性应付项目的增加-161,733,955.67-139,156,943.47-
  其他500,853.27-40,491,699.7-
  不涉及现金收支的投资和筹资活动金额其他项目2,789,810.65-2,055,457.87-
  现金的期末余额228,238,759.15-488,325,966.27-
  减:现金的期初余额488,325,966.27-700,957,397.81-
  现金及现金等价物的净增加额-260,087,207.12--212,631,431.54-
公告日期2025-08-292025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑